Grewal P. Tildrakizumab in patients with metabolic syndrome: A novel approach. Can Dermatol Today [Internet]. 2021 Mar. 1 [cited 2025 Apr. 4];2(s03):9–11. Available from: https://canadiandermatologytoday.com/article/view/2-s03-grewal